186 related articles for article (PubMed ID: 9365996)
1. Neuroleptic intolerance.
Hansen TE; Casey DE; Hoffman WF
Schizophr Bull; 1997; 23(4):567-82. PubMed ID: 9365996
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of antipsychotic drugs.
Malhotra AK; Litman RE; Pickar D
Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
[TBL] [Abstract][Full Text] [Related]
3. Medical complications of new antipsychotic drugs.
Umbricht D; Kane JM
Schizophr Bull; 1996; 22(3):475-83. PubMed ID: 8873298
[TBL] [Abstract][Full Text] [Related]
4. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of antipsychotic drugs.
Whitworth AB; Fleischhacker WW
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():21-7. PubMed ID: 7622830
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment of schizophrenia.
Levinson DF
Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
[TBL] [Abstract][Full Text] [Related]
7. [Iatrogenic extrapyramidal disorders].
Ludin HP
Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
van Harten PN; Matroos GE; Hoek HW; Kahn RS
Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neurobiologic implications of antipsychotic-induced movement disorders.
Rubin EH; Zorumski CF
Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769
[No Abstract] [Full Text] [Related]
10. Side effect profiles of new antipsychotic agents.
Casey DE
J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
Marsden CD; Jenner P
Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342
[TBL] [Abstract][Full Text] [Related]
12. A protocol for the diagnosis and treatment of extrapyramidal symptoms of neuroleptic drugs.
Bickal T
Nurse Pract; 1987 Jan; 12(1):25, 29, 32 passim. PubMed ID: 2880325
[TBL] [Abstract][Full Text] [Related]
13. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
14. Treating extrapyramidal reactions: some current issues.
Gelenberg AJ
J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
[TBL] [Abstract][Full Text] [Related]
15. Motor and mental side effects of clozapine.
Gerlach J; Peacock L
J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
[TBL] [Abstract][Full Text] [Related]
16. The relationship of pharmacology to side effects.
Casey DE
J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
[TBL] [Abstract][Full Text] [Related]
17. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects.
Baldessarini RJ
Postgrad Med; 1979 Apr; 65(4):123-8. PubMed ID: 34142
[TBL] [Abstract][Full Text] [Related]
18. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
Rodnitzky RL; Keyser DL
Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
Richardson MA; Haugland G; Craig TJ
Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
[TBL] [Abstract][Full Text] [Related]
20. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A
Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
